Shark Tank ’s Mark Cuban speaks out on Ozempic, weight-loss drugs
Ozempic, the medicine known generically as semaglutide, was approved by the U.S. Food and Drug Administration (FDA) in 2017 for type 2 diabetes patients. But the drug, manufactured by Denmark-based company Novo Nordisk (NVO) , has a side effect that is changing the way many people feel about one…#fda #denmark #novonordisk #nvo #elililly #lly #mounjaro #markcuban #dallas #sharktank
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cuba Health | Denmark Health | Diabetes | Diabetes Type 2 | Endocrinology | Food and Drug Administration (FDA) | Health | Weight Loss